Cargando…
Neurotoxicity of novel cancer immunotherapies
Autores principales: | Willis, M. D., Robertson, N. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647598/ https://www.ncbi.nlm.nih.gov/pubmed/31254062 http://dx.doi.org/10.1007/s00415-019-09444-4 |
Ejemplares similares
-
Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2
por: Willis, M. D., et al.
Publicado: (2020) -
Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018) -
Chronic traumatic encephalopathy: identifying those at risk and understanding pathogenesis
por: Willis, M. D., et al.
Publicado: (2017) -
Multiple sclerosis: early indicators of disease and assessing future risk
por: Willis, M. D., et al.
Publicado: (2020) -
Technology-assisted recovery of walking after spinal cord injury
por: MD, Willis, et al.
Publicado: (2019)